Literature DB >> 22005259

NF-κB, JNK and p53 pathways are involved in tubeimoside-1-induced apoptosis in HepG2 cells with oxidative stress and G₂/M cell cycle arrest.

Yan Yin1, Wei Chen, Changyan Tang, Hanjing Ding, Jongchol Jang, Meizhi Weng, Yongjun Cai, Guolin Zou.   

Abstract

Tubeimoside-1 is a triterpenoid saponin extracted from the traditional Chinese herb Bolbostemma paniculatum (Maxim.) Franquet (Cucurbitaceae). We investigated the cytotoxic effect and apoptosis mechanism of tubeimoside-1. Tubeimoside-1 was cytotoxic in seven human cancer cell lines, with HepG2 the most sensitive. Tubeimoside-1 induced apoptosis of HepG2 cells dose and time dependently. Both the extrinsic and intrinsic pathways were triggered by tubeimoside-1. Caspase-3, -8 and -9 were activated and the expression of Fas, Fas ligand, Bcl-2, Bak and Bax was regulated. Moreover, tubeimoside-1 induced accumulation of reactive oxygen species and arrested cell cycle at the G(2)/M phase, thus contributing to apoptosis, through signaling regulation by tumor necrosis factor α, nuclear factor κB (NF-κB), Jun N-terminal kinase (JNK) and p53. We provide further insight into the tubeimoside-1 cytotoxic effect for antitumor chemotherapeutic treatment.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22005259     DOI: 10.1016/j.fct.2011.10.001

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  21 in total

1.  Tubeimoside-1 (TBMS1) inhibits lung cancer cell growth and induces cells apoptosis through activation of MAPK-JNK pathway.

Authors:  Wenli Hao; Shuai Wang; Zhenli Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Tubeimoside-1 inhibits the growth and invasion of colorectal cancer cells through the Wnt/β-catenin signaling pathway.

Authors:  Quan Bian; Pengfei Liu; Junping Gu; Baoji Song
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Intrinsic apoptotic pathway and G2/M cell cycle arrest involved in tubeimoside I-induced EC109 cell death.

Authors:  Yang Xu; Guanghui Wang; Quancheng Chen; Ting Lin; Zhiping Zeng; Qiang Luo; Jie Liu; Cuiling Sun
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

4.  Tubeimoside-1 induces oxidative stress-mediated apoptosis and G0/G1 phase arrest in human prostate carcinoma cells in vitro.

Authors:  Jing-Bo Yang; Muhammad Khan; Yang-Yang He; Min Yao; Yong-Ming Li; Hong-Wen Gao; Tong-Hui Ma
Journal:  Acta Pharmacol Sin       Date:  2016-06-13       Impact factor: 6.150

5.  Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway.

Authors:  Geng Jia; Qiang Wang; Rong Wang; Danni Deng; Lian Xue; Naiyuan Shao; Yi Zhang; Xiwei Xia; Feng Zhi; Yilin Yang
Journal:  Onco Targets Ther       Date:  2015-01-30       Impact factor: 4.147

Review 6.  Development of Certain Protein Kinase Inhibitors with the Components from Traditional Chinese Medicine.

Authors:  Minghua Liu; Ge Zhao; Shousong Cao; Yangyang Zhang; Xiaofang Li; Xiukun Lin
Journal:  Front Pharmacol       Date:  2017-01-09       Impact factor: 5.810

7.  TPEN induces apoptosis independently of zinc chelator activity in a model of acute lymphoblastic leukemia and ex vivo acute leukemia cells through oxidative stress and mitochondria caspase-3- and AIF-dependent pathways.

Authors:  Miguel Mendivil-Perez; Carlos Velez-Pardo; Marlene Jimenez-Del-Rio
Journal:  Oxid Med Cell Longev       Date:  2012-12-23       Impact factor: 6.543

8.  Effects of tubeimoside-1 on the proliferation and apoptosis of BGC823 gastric cancer cells in vitro.

Authors:  Yi Zhang; Xiao-Man Xu; Meng Zhang; Dan Qu; Hui-Yan Niu; Xue Bai; Liang Kan; Ping He
Journal:  Oncol Lett       Date:  2013-01-08       Impact factor: 2.967

Review 9.  Killing cancer with platycodin D through multiple mechanisms.

Authors:  Muhammad Khan; Amara Maryam; He Zhang; Tahir Mehmood; Tonghui Ma
Journal:  J Cell Mol Med       Date:  2015-12-09       Impact factor: 5.310

10.  Tubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft model.

Authors:  Yuan Gu; Christina Körbel; Claudia Scheuer; Anca Nenicu; Michael D Menger; Matthias W Laschke
Journal:  Oncotarget       Date:  2016-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.